FOXI3 establishes the ectodermal niche in pharyngeal arches for cranial neural crest cells and their lineages

Abstract

Craniofacial development relies on the migration of cranial neural crest cells (CNCCs) to the first and second pharyngeal arches, followed by their differentiation into various cell types during embryogenesis. Although the CNCC migration has been well-studied, the role of the niche in relation to CNCC remains unclear. Variants in FOXI3 have been implicated in craniofacial microsomia (CFM), yet the molecular mechanisms remain unexplored. FOXI3 is expressed in the ectoderm and auricle epidermis, but not in CNCCs or cartilage. Deletion of Foxi3 in the mouse CNCCs did not disrupt mandible and auricular development, further confirming that FOXI3 does not directly regulate CNCCs. However, Foxi3 deficiency in the ectoderm reduced the production of chondrogenesis-related cytokines derived from ectodermal cells, such as TGF-β1. This impairment affected CNCC proliferation through cell communication, subsequently altering the development of the mandible and auricle. These results emphasize the critical role of FOXI3 in establishing the microenvironment supporting CNCC function. Furthermore, FOXI3 directly regulates target genes associated with translation, thereby orchestrating cytokine production in epidermal cells. The validation using auricle sample from a CFM patient carrying FOXI3 mutation further supports our findings. These insights highlight the function of FOXI3 in creating the niche necessary for CNCC development and provide a basis for understanding the molecular mechanisms driving CFM pathogenesis.

References

[1] Graham A. Development of the pharyngeal arches. Am. J. Med. Genet. A, 2003, 119A: 251-256

[2] Kulesa PM, Bailey CM, Kasemeier-Kulesa JC, McLennan R. Cranial neural crest migration: new rules for an old road. Dev. Biol., 2010, 344: 543-554

[3] Liao Jet al.. Gene regulatory network from cranial neural crest cells to osteoblast differentiation and calvarial bone development. Cell. Mol. Life Sci., 2022, 79: 158

[4] Abu-Issa R, Smyth G, Smoak I, Yamamura K, Meyers EN. Fgf8 is required for pharyngeal arch and cardiovascular development in the mouse. Development, 2002, 129: 4613-4625

[5] Mukherjee Aet al.. A review of FOXI3 regulation of development and possible roles in cancer progression and metastasis. Front. Cell Dev. Biol., 2018, 6: 69

[6] Mao Ket al.. FOXI3 pathogenic variants cause one form of craniofacial microsomia. Nat. Commun., 2023, 14 2026

[7] Quiat, D. et al. Damaging variants in FOXI3 cause microtia and craniofacial microsomia. Genet. Med. 25, 143–150 (2023).

[8] Bernstock JDet al.. Recurrent microdeletions at chromosome 2p11.2 are associated with thymic hypoplasia and features resembling DiGeorge syndrome. J. Allergy Clin. Immunol., 2020, 145: 358-367

[9] Drogemuller Cet al.. A mutation in hairless dogs implicates FOXI3 in ectodermal development. Science, 2008, 321: 1462

[10] Shirokova Vet al.. Foxi3 deficiency compromises hair follicle stem cell specification and activation. Stem Cells, 2016, 34: 1896-1908

[11] Tassano Eet al.. Congenital aural atresia associated with agenesis of internal carotid artery in a girl with a FOXI3 deletion. Am. J. Med. Genet. A, 2015, 167A: 537-544

[12] Edlund RK, Ohyama T, Kantarci H, Riley BB, Groves AK. Foxi transcription factors promote pharyngeal arch development by regulating formation of FGF signaling centers. Dev. Biol., 2014, 390: 1-13

[13] Chen X, Zhang R. Microtia epigenetics: an overview of review and new viewpoint. Medicine, 2019, 98 e17468

[14] Rooijers Wet al.. Hearing impairment and ear anomalies in craniofacial microsomia: a systematic review. Int. J. Oral Maxillofac. Surg., 2022, 51: 1296-1304

[15] Zhang TYet al.. International consensus recommendations on microtia, aural atresia and functional ear reconstruction. J. Int. Adv. Otol., 2019, 15: 204-208

[16] Fuchs JC, Tucker AS. Development and integration of the ear. Curr. Top. Dev. Biol., 2015, 115: 213-232

[17] Ohyama T, Groves AK. Expression of mouse Foxi class genes in early craniofacial development. Dev. Dyn., 2004, 231: 640-646

[18] Ankamreddy, H., Thawani, A., Birol, O., Zhang, H. & Groves, A. K. Foxi3(GFP) and Foxi3(CreER) mice allow identification and lineage labeling of pharyngeal arch ectoderm and endoderm, and tooth and hair placodes. Dev. Dyn. 252, 1462–1470 (2023).

[19] Singh S, Jangid RK, Crowder A, Groves AK. Foxi3 traca C-terminal transactivation domain and regulated by the Protein Phosphatase 2A (PP2A) complex.. Sci. Rep., 2018, 8: 17249

[20] Iurlaro Met al.. A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome Biol., 2013, 14 R119

[21] Coda, D. M. et al. A network of transcription factors governs the dynamics of NODAL/Activin transcriptional responses. J. Cell Sci. 135, jcs259972 (2022).

[22] Shirokova Vet al.. Expression of Foxi3 is regulated by ectodysplasin in skin appendage placodes. Dev. Dyn., 2013, 242: 593-603

[23] Timberlake ATet al.. Haploinsufficiency of SF3B2 causes craniofacial microsomia. Nat. Commun., 2021, 12 4680

[24] Gavalas Aet al.. Hoxa1 and Hoxb1 synergize in patterning the hindbrain, cranial nerves and second pharyngeal arch. Development, 1998, 125: 1123-1136

[25] Kanzler B, Kuschert SJ, Liu YH, Mallo M. Hoxa-2 restricts the chondrogenic domain and inhibits bone formation during development of the branchial area. Development, 1998, 125: 2587-2597

[26] Moraes F, Novoa A, Jerome-Majewska LA, Papaioannou VE, Mallo M. Tbx1 is required for proper neural crest migration and to stabilize spatial patterns during middle and inner ear development. Mech. Dev., 2005, 122: 199-212

[27] Kahata, K., Dadras, M. S. & Moustakas, A. TGF-beta family signaling in epithelial differentiation and epithelial-mesenchymal transition. Cold Spring Harb. Perspect. Biol. 10, a022194 (2018).

[28] Ferretti E, Hadjantonakis AK. Mesoderm specification and diversification: from single cells to emergent tissues. Curr. Opin. Cell Biol., 2019, 61: 110-116

[29] Mahapatro, M., Erkert, L. & Becker, C. Cytokine-mediated crosstalk between immune cells and epithelial cells in the gut. Cells10, 111 (2021).

[30] Levinson C, Lee M, Applegate LA, Zenobi-Wong M. An injectable heparin-conjugated hyaluronan scaffold for local delivery of transforming growth factor beta1 promotes successful chondrogenesis. Acta Biomater., 2019, 99: 168-180

[31] Kurakazu Iet al.. FOXO1 transcription factor regulates chondrogenic differentiation through transforming growth factor beta1 signaling. J. Biol. Chem., 2019, 294: 17555-17569

[32] Zhang X, Pu X, Pi C, Xie J. The role of fibroblast growth factor 7 in cartilage development and diseases. Life Sci., 2023, 326: 121804

[33] Qiu Cet al.. A single-cell time-lapse of mouse prenatal development from gastrula to birth. Nature, 2024, 626: 1084-1093

[34] Edlund RK, Birol O, Groves AK. The role of foxi family transcription factors in the development of the ear and jaw. Curr. Top. Dev. Biol., 2015, 111: 461-495

[35] Hayashi S, Lewis P, Pevny L, McMahon AP. Efficient gene modulation in mouse epiblast using a Sox2Cre transgenic mouse strain. Mech. Dev., 2002, 119: S97-S101

[36] Boukamp Pet al.. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol., 1988, 106: 761-771

[37] Gu Yet al.. Chondrocytes from congenital microtia possess an inferior capacity for in vivo cartilage regeneration to healthy ear chondrocytes. J. Tissue Eng. Regen. Med., 2018, 12: e1737-e1746

[38] Housmans Bet al.. Synovial fluid from end-stage osteoarthritis induces proliferation and fibrosis of articular chondrocytes via MAPK and RhoGTPase signaling. Osteoarthr. Cartil., 2022, 30: 862-874

[39] Ma L, Zhang R, Li D, Qiao T, Guo X. Fluoride regulates chondrocyte proliferation and autophagy via PI3K/AKT/mTOR signaling pathway. Chem. Biol. Interact., 2021, 349: 109659

[40] Grashoff C, Aszodi A, Sakai T, Hunziker EB, Fassler R. Integrin-linked kinase regulates chondrocyte shape and proliferation. EMBO Rep., 2003, 4: 432-438

[41] Wu Qet al.. Astrocytic YAP protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model through TGF-beta signaling. Theranostics, 2021, 11: 8480-8499

[42] Hasegawa Yet al.. GVHD targets organoid-forming bile duct stem cells in a TGF-beta-dependent manner. Blood, 2024, 144: 904-913

[43] Kaya-Okur HS, Janssens DH, Henikoff JG, Ahmad K, Henikoff S. Efficient low-cost chromatin profiling with CUT&Tag. Nat. Protoc., 2020, 15: 3264-3283

[44] Holstege FC, Clevers H. Transcription factor target practice. Cell, 2006, 124: 21-23

[45] Spitz F, Furlong EE. Transcription factors: from enhancer binding to developmental control. Nat. Rev. Genet., 2012, 13: 613-626

[46] Breuer Met al.. CHD7 regulates craniofacial cartilage development via controlling HTR2B expression. J. Bone Miner. Res., 2024, 39: 498-512

[47] Bernier FPet al.. Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome. Am. J. Hum. Genet., 2012, 90: 925-933

[48] Bower Met al.. Update of PAX2 mutations in renal coloboma syndrome and establishment of a locus-specific database. Hum. Mutat., 2012, 33: 457-466

[49] Isbel L, Grand RS, Schubeler D. Generating specificity in genome regulation through transcription factor sensitivity to chromatin. Nat. Rev. Genet., 2022, 23: 728-740

[50] Schuller AP, Wu CC, Dever TE, Buskirk AR, Green R. eIF5A functions globally in translation elongation and termination. Mol. Cell, 2017, 66: 194-205

[51] Kar RKet al.. Neuron-specific ablation of eIF5A or deoxyhypusine synthase leads to impairments in growth, viability, neurodevelopment, and cognitive functions in mice. J. Biol. Chem., 2021, 297: 101333

[52] De Colibus L, Stunnenberg M, Geijtenbeek T. DDX3X structural analysis: implications in the pharmacology and innate immunity. Curr. Res. Immunol., 2022, 3: 100-109

[53] Lai MC, Lee YH, Tarn WY. The DEAD-box RNA helicase DDX3 associates with export messenger ribonucleoproteins as well as tip-associated protein and participates in translational control. Mol. Biol. Cell, 2008, 19: 3847-3858

[54] Ryan CS, Schroder M. The human DEAD-box helicase DDX3X as a regulator of mRNA translation. Front. Cell Dev. Biol., 2022, 10: 1033684

[55] Chen Xet al.. Identification and functional characterization of pathogenic FOXI3 variants in craniofacial microsomia.. J. Genet. Genom., 2025, 52: 706-709

[56] Chadjichristos Cet al.. Down-regulation of human type II collagen gene expression by transforming growth factor-beta 1 (TGFbeta1) in articular chondrocytes involves SP3/SP1 ratio.. J. Biol. Chem., 2002, 277: 43903-43917

[57] Tekari A, Luginbuehl R, Hofstetter W, Egli RJ. Transforming growth factor beta signaling is essential for the autonomous formation of cartilage-like tissue by expanded chondrocytes.. PLoS ONE, 2015, 10: e120857

[58] Poncelet AC, de Caestecker MP, Schnaper HW. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.. Kidney Int., 1999, 56: 1354-1365

[59] Solomon KS, Logsdon JJ, Fritz A. Expression and phylogenetic analyses of three zebrafish FoxI class genes. Dev. Dyn., 2003, 228: 301-307

[60] Khatri SB, Groves AK. Expression of the Foxi2 and Foxi3 transcription factors during development of chicken sensory placodes and pharyngeal arches. Gene Expr. Patterns, 2013, 13: 38-42

[61] Mattes B, Scholpp S. Emerging role of contact-mediated cell communication in tissue development and diseases. Histochem. Cell Biol., 2018, 150: 431-442

[62] Jussila Met al.. Suppression of epithelial differentiation by Foxi3 is essential for molar crown patterning. Development, 2015, 142: 3954-3963

[63] Birol Oet al.. The mouse Foxi3 transcription factor is necessary for the development of posterior placodes. Dev. Biol., 2016, 409: 139-151

[64] Kurth Iet al.. The forkhead transcription factor Foxi1 directly activates the AE4 promoter. Biochem. J., 2006, 393: 277-283

[65] Mo Jet al.. DDX3X: structure, physiologic functions and cancer. Mol. Cancer, 2021, 20 38

[66] Parreiras-e-Silva LTet al.. Evidences of a role for eukaryotic translation initiation factor 5A (eIF5A) in mouse embryogenesis and cell differentiation. J. Cell. Physiol., 2010, 225: 500-505

[67] Templin AT, Maier B, Nishiki Y, Tersey SA, Mirmira RG. Deoxyhypusine synthase haploinsufficiency attenuates acute cytokine signaling. Cell Cycle, 2011, 10: 1043-1049

[68] Maier B, Tersey SA, Mirmira RG. Hypusine: a new target for therapeutic intervention in diabetic inflammation. Discov. Med., 2010, 10: 18-23

[69] Conway SJ, Kaartinen V. TGFbeta superfamily signaling in the neural crest lineage. Cell Adhes. Migr., 2011, 5: 232-236

[70] Hariyanto NI, Yo EC, Wanandi SI. Regulation and signaling of TGF-beta autoinduction. Int. J. Mol. Cell. Med., 2021, 10: 234-247

[71] Susaki EAet al.. Whole-brain imaging with single-cell resolution using chemical cocktails and computational analysis. Cell, 2014, 157: 726-739

[72] Jiang Xet al.. Normal fate and altered function of the cardiac neural crest cell lineage in retinoic acid receptor mutant embryos. Mech. Dev., 2002, 117: 115-122

[73] Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav. Brain Res., 2001, 125: 279-284

[74] Vento-Tormo Ret al.. Single-cell reconstruction of the early maternal-fetal interface in humans. Nature, 2018, 563: 347-353

[75] Qiu Xet al.. Single-cell mRNA quantification and differential analysis with Census. Nat. Methods., 2017, 14: 309-315

[76] Gulati GSet al.. Single-cell transcriptional diversity is a hallmark of developmental potential. Science, 2020, 367: 405-411

Funding

National Natural Science Foundation of China (82271889, 82572117), National Key Research and Development Program of China (No. 2021YFC2701000), and Shanghai Natural Science Foundation (23ZR1409400)

Shanghai Natural Science Foundation (24ZR1409400)

National Natural Science Foundation of China (82172105)

National Natural Science Foundation of China (No. 82371173)

RIGHTS & PERMISSIONS

The Author(s)